Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. NSAID Use and Incident Cognitive Impairment in a Population-based Cohort 2016-04-01
  2. Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment? 2010-05-21

Studies

2 studies carry this tag.

Date range

2010 to 2016

Top journals

  • Alzheimer disease and associated disorders 1
  • Frontiers in aging neuroscience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. NSAID Use and Incident Cognitive Impairment in a Population-based Cohort

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Alzheimer disease and associated disorders 2016-04-01 Risk factors

    Nonsteroidal anti-inflammatory drugs (NSAIDs) may prevent dementia, but previous studies have yielded conflicting results.

  2. Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Frontiers in aging neuroscience 2010-05-21 Clinical trials

    Several epidemiological studies suggest that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) may protect subjects carrying one or more epsilon4 allele of the apolipoprotein E (APOE epsilon4) against the onset of Alzheimer's disease (AD).

All topic tags with their study counts